Treatment of central precocious puberty: Lessons from a 15 years prospective trial

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 1, 2000, Pages 747-758

  Partsch, C J ^a   Heger, S ^a   Sippell, W G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Final height; GnRH agonist; Height prediction; Outcome; Triptorelin

Indexed keywords

TRIPTORELIN;

AGE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MULTICENTER STUDY; ONSET AGE; PRECOCIOUS PUBERTY; PUBERTY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0033867281     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2000.13.s1.747     Document Type: Conference Paper

References (52)

1. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing-hormone-releasing hormone analogue nasal spray
2. Treatment of central precocious puberty with depot leuprorelin
3. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone
4. Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: A potential new treatment for idiopathic precocious puberty
5. Suppression of gonadotropin secretion in a long-acting gonadotropin-releasing hormone analog (Leuprolide acetate, Lupron-Depot) in children with precocious puerbty
6. 6-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty
7. Treatment of central precocious puberty with depot lupron
8. Treatment of children with central precocious puberty by a slow-release GnRH agonist
9. Hormonal evaluation during and after long-term treatment with a slow-release GnRH agonist of children with central precocious puberty: Effect on final height
10. Treatment of progressive central precocious puberty with leuprorelin depot
11. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp-6-LHRH microcapsules
12. Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatments
13. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: Influence on growth and predicted final height
14. Pathophysiology and treatment of sexual precocity
15. Modifying the outcome of complete precocius puberty
16. Precocious puberty: Who has it? Who should be treated?
17. Self-remitting or transient central precocious puberty
18. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs
19. Final heights in girls with central precocious puberty (CPP) following GnRH agonist (GnRHa)-induced pituitary-gonadal suppression
20. Adult height in girls with tree precocious puberty
21. Final height after long-term treatment with Triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment
22. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function
23. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-Trp-6-LHRH
24. Final height in central precocious puberty after long-term treatment with a slow release GnRH agonist
25. Long term effect of gonadotropin-releasing hormone agonist therapy on final height and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years
26. Longitudinale Korperentwicklung gesunder Kinder II. Grosse, Gewicht, Hautfettfalten von Kindern im Alter Von 1.5 bis 16 Jahren
27. Longitudinale Korperentwicklung gesunder Kinder Von 0-18 Jahren
28. Body mass index variations: Centiles from birth to 87 years
29. Tables for predicting adult height from skeletal age: Revised use with the Greulich-Pyle hand standards
30. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic precocious puberty
31. Precocious puberty in girls: Early diagnosis of a slowly progressing variant
32. Unsustained or slowly progressive puberty in young girls: Initial presentation and long-term follow-up of 20 untreated patients
33. Preserving adult height potential in girls with idiopathic true precocious puberty
34. Timing of discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty
35. Randomised trial of LHRH anlogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years
36. Precocious puberty. A report of 96 cases
37. Treatment of precocious puberty with cyproterone acetate
38. Medroxyprogesterone therapy for sexual precocity in girls
39. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty
40. Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotropin-releasing hormone (Buserelin)
41. Final height in girls with slowly progressive untreated central precocious puberty
42. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue
43. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females
44. Lack of effect of GnRH agonists on final height in girls with advanced puberty: A randomized long-term pilot study
45. The effects of cyproterone acetate on statural growth in children with precocious puberty
46. The long-term effect of cyproterone acetate on growth in girls with idio-pathic precocious puberty
47. Final height of girls with central precocious puberty - Untreated as compared to treated with GnRH analog or with cyproterone acetate
48. Adult height in precocious puberty after long-term treatment with deslorelin
49. Final height of patients with true precocious puberty, comparison of two different LHRH analogue treatments
50. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy